Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. - Wikidata - wikimedia - TriplyDB

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

http://www.wikidata.org/entity/Q37082773

about

Pea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis.Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.Probiotics and gastrointestinal disease: successes, problems and future prospects.An in vitro evaluation of antioxidant and colonic microbial profile levels following mushroom consumption.Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.Adherence to an elemental diet for preventing postoperative recurrence of Crohn's disease.

P2860

Q35550110-7274D354-599F-4371-8409-ADDE7118FE63 Q35686196-8CFC6CAB-CE0F-42BB-B907-0F650E7CB3CF Q35895310-0AD5EA5E-7524-49E0-AA83-6F56096516DA Q37460752-E37E32DF-253E-47A7-A125-3AF4270E3BA5 Q42583889-5786781F-861F-40C3-91FF-8C245C574F8B Q43937782-2992D638-011C-4C5A-B73C-99918D366CFB Q50629942-D6E012F4-50C3-4577-8394-B771066D5956

P2860

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

http://www.wikidata.org/entity/Q37082773

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@en

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@nl

type

label

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@en

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@nl

prefLabel

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@en

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@nl

P1433

Q37082773-42BE2AFD-73C8-4DB5-9A36-20176560DFAA

P1476

Q37082773-AAF8C572-2BE1-459F-AE71-2AB38CD8DB20

P2093

Q37082773-53913BC3-EF3A-4B13-922B-369F30D388FA

Q37082773-764334F6-E3F6-49F1-B427-DEC93A4061A0

P2860

Q37082773-01771121-4913-439B-AB49-8FDDA04ACCBF

Q37082773-02ADEC33-43EA-4C84-A119-02A871BA6625

Q37082773-09B4A47D-2D7B-4D25-8B88-535D67643F5E

Q37082773-0CE9F943-0A5B-490B-A5CD-678ED7A348CF

Q37082773-0EB310BC-8F17-4BB5-9DF9-99894994B2EC

Q37082773-0FB33933-07BE-4A98-BBD9-5182B30421BC

Q37082773-10BA06FD-315A-4BD8-8DEF-5E938AB14201

Q37082773-123FDD2C-0FF6-48ED-AFE9-79782703DB89

Q37082773-197E0890-0973-4D2A-BF44-DEC12C5AE28F

Q37082773-1A7F05E7-B895-42A7-BEA4-0E9164402F8F

P304

Q37082773-9B168D5F-46F8-4ABA-A6B7-0121AFEB7861

P31

Q37082773-7C31BC57-A15E-4923-AC43-0FEB7F06ABAA

P356

Q37082773-BA37C248-2331-40CA-9F67-8570927FFBA8

P407

Q37082773-04E4F104-2819-45A1-82F5-4752E7CD9DC9

P433

Q37082773-3FD4C91D-464E-4AB5-96F7-E9B2CDB11FC6

P478

Q37082773-06300BC3-73D3-49A2-ADED-8B1AAB4B6C1D

P577

Q37082773-1E292FAB-F2F6-4A59-B92B-0D897C9025E4

P698

Q37082773-DE762566-1CB9-46AE-BF7C-E3A3246E8685

P921

Q37082773-7DEEFFD3-6761-4466-8152-121CDD2CB0F6

P356

14728222.12.3.301

P1433

Expert Opinion on Therapeutic Targets

P1476

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.

@en

P2093

Keiichi Mitsuyama

http://www.w3.org/2001/XMLSchema#string

Michio Sata

http://www.w3.org/2001/XMLSchema#string

P2860

Defects in mucosal immunity leading to Crohn's disease

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Diversity of the human intestinal microbial flora

Potential uses of probiotics in clinical practice

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Saccharomyces boulardii in maintenance treatment of Crohn's disease

P304

301-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.12.3.301

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18269340

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases